ETHYL 3-(2,6-DICHLOROPHENYL)-5-CYCLOPROPYLISOXAZOLE-4-CARBOXYLATE, 95.0%, 100mg

3-Bromoanisic acid, 95.0%, 5g

5,6,7,8-Tetrahydro-3H-benzo[4,5]thieno[2,3-d]-pyrimidin-4-one, 90.0%, 25g

METHYL 6-FLUORO-5-METHYLPYRIDINE-3-CARBOXYLATE, 95.0%, 100mg

5-Fluoro-3-hydrazonoindolin-2-one, 97%, 500mg

1-(3-chloro-4-methylphenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 5g

1,4-Dichlorobenzène, >=99%, pour la synthèse, 2,5 kg, emballage plastique.

4,4',4'',4'''-(1,4-Phenylenebis(azanetriyl))tetrabenzoicacid, 95%, 250mg

3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole, 95.0%, 1g

[(2R)-5-oxo-2-pyrrolidinyl]acetic acid, 95.0%, 1g

1-(4-Methyl-benzyl)-4-nitro-1H-pyrazole, 250mg

3-Fluorophenetole, 95.0%, 100g

1,5-Dibromo-2,2,3,3,4,4-hexafluoropentane, 97.0%, 5g